Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations
-
* Corresponding author: Francisco J de Abajo fabajo@agemed.es
1 División de Farmacoepidemiología y Farmacovigilancia, Agencia Española del Medicamento, Madrid, Spain
2 Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain
BMC Clinical Pharmacology 2001, 1:1-1 doi:10.1186/1472-6904-1-1
Published: 13 February 2001Additional files
Appendix 1:
Format: DOC Size: 20KB Download file
This file can be viewed with: Microsoft Word Viewer
Appendix 2:
Format: DOC Size: 20KB Download file
This file can be viewed with: Microsoft Word Viewer
Appendix 3:
Format: DOC Size: 19KB Download file
This file can be viewed with: Microsoft Word Viewer
Appendix 4:
Format: DOC Size: 21KB Download file
This file can be viewed with: Microsoft Word Viewer
